SLC2A1 and breast neoplasm: Similarly, a GLUT inhibitor phloretin has been demonstrated to increase phosphorylation of JNK, p38, and ERK in breast tumor cells and NSCLC cells (Kim et al., 2009; Min et al., 2015).